
Scott Lowe, researcher: ‘Governments must fund science. Pharmaceutical companies want to help, but they also want to make money’
The geneticist speaks with EL PAÍS about the advances and challenges in the field of cancer research

The geneticist speaks with EL PAÍS about the advances and challenges in the field of cancer research

The experimental drug is an ultrasensitive version of CAR-T therapies, which have already revolutionized the treatment of leukemias and lymphomas